Bing Sen Guo
Directeur/Membre du Conseil chez CARSGEN THERAPEUTICS HOLDINGS LIMITED
Provenance du réseau au premier degré de Bing Sen Guo
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bing Sen Guo via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
CARsgen Therapeutics Co. Ltd.
 CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer | |
| Fudan University | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
CPA Australia Ltd.
 CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
Fujian Dingwo Investment Ltd.
 Fujian Dingwo Investment Ltd. Financial ConglomeratesFinance Fujian Dingwo Investment Ltd. provides investment services. The private company is based in Wuhan, China. | Financial Conglomerates | Corporate Officer/Principal | |
| University of Beihua | College/University | Undergraduate Degree | |
| Shanghai Synchrotron Radiation Facility | Corporate Officer/Principal | ||
| Nanjing University | College/University | Undergraduate Degree | |
| Shanghai Key Laboratory For Nucleic Acid Chemistry & Nanomedic | Director/Board Member | ||
| Shanghai Jiao Tong University | College/University | Corporate Officer/Principal | |
| Fujian Dingwo Investment Management Ltd. | Chief Executive Officer | ||
| Xiamen University | College/University | Undergraduate Degree | |
| Xiamen Runtang Tianyi Investment Management Ltd. | Corporate Officer/Principal | ||
| Genito Urinary Medical Oncologists of Canada Gumo | Corporate Officer/Principal | ||
| Quanzhou Jiatai Footwear Ltd. | Corporate Officer/Principal | ||
| MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD. | Medical Specialties | Director/Board Member | |
| Providence College & Theological Seminary | College/University | Doctorate Degree | |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Parma | College/University | Doctorate Degree | |
Medisix Therapeutics, Inc.
 Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Medisix Therapeutics, Inc. develops novel cellular therapies to address T cell malignancies. The company is headquartered in Singapore. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Suzhou Kaifeng Zhengde Investment Management Co. Ltd. | Corporate Officer/Principal | ||
| MGI TECH CO., LTD. | Biotechnology | Director/Board Member | |
Shanghai Bioveda Investment Management Consulting Co. Ltd.
 Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Investment Managers | Private Equity Analyst | |
| Xiangya School of Medicine | College/University | Undergraduate Degree | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Nankai University | College/University | Graduate Degree | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MorphoSys US, Inc. | General Counsel | ||
| Capital University of Economics & Business | College/University | Doctorate Degree | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Georgia | College/University | Masters Business Admin | |
| Central South University | College/University | Undergraduate Degree | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin | |
| Shanghai Loyal Valley Investment Management Ltd. | Corporate Officer/Principal | ||
| Boston University | College/University | Undergraduate Degree | |
PricewaterhouseCoopers Consultants (Shenzhen) Ltd.
 PricewaterhouseCoopers Consultants (Shenzhen) Ltd. Other Consumer ServicesConsumer Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers Consultants (Shenzhen) Ltd. is a Chinese company that provides assurance, tax and advisory services. The company is based in Shenzhen, China. | Other Consumer Services | Corporate Officer/Principal | |
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SciClone Pharmaceuticals (China) Co. Ltd.
 SciClone Pharmaceuticals (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of SciClone Pharmaceuticals (Holdings) Ltd., SciClone Pharmaceuticals (China) Co. Ltd. manufactures specialty pharmaceutical products. The company is based in Shanghai, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Pharmaceuticals: Major | Director of Finance/CFO | |
| Connect Biopharma (Shanghai) Ltd. | Corporate Officer/Principal | ||
| Shandong University | College/University | Graduate Degree | |
| Sun Yat-Sen University | College/University | Doctorate Degree | |
Yunzhou Biosciences (Guangzhou) Co., Ltd.
 Yunzhou Biosciences (Guangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Yunzhou Biosciences (Guangzhou) Co., Ltd. engages in research and development of gene delivery technology solutions. It offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs. The company provides custom vectors for both viral and non-viral gene delivery and it currently tailor-build over 80,000 vectors a year for tens of thousands of researchers around the world. Yunzhou Biosciences (Guangzhou) was founded by Tian Lan and on March 14, 2014 and is headquartered in Guangzhou, China. | Miscellaneous Commercial Services | Director/Board Member | |
Guangzhou Koncen Bioscience Co., Ltd.
 Guangzhou Koncen Bioscience Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Guangzhou Koncen Bioscience Co., Ltd. engages in the research, development, production, and sale of blood purification products. It offers hemodialysis powder, hemodialysis concentrate, hemodialysis filters, protein A immunosorbent columns, disposable bilirubin plasma adsorbers, and hemodialysis treatment services. The company was founded by Xiao Yuan Chen on April 5, 2001 and is headquartered in Guangzhou, China. | Miscellaneous Commercial Services | Director/Board Member | |
| Southeast University | College/University | Undergraduate Degree | |
| INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Chine | 32 |
| Etats-Unis | 14 |
| Canada | 3 |
| Australie | 2 |
| Italie | 2 |
Sectorielle
| Consumer Services | 19 |
| Health Technology | 14 |
| Commercial Services | 7 |
| Finance | 3 |
| Retail Trade | 2 |
Opérationnelle
| Corporate Officer/Principal | 36 |
| Director/Board Member | 25 |
| Undergraduate Degree | 12 |
| Independent Dir/Board Member | 11 |
| Corporate Secretary | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Tak Young So | 15 |
| Wing Yat Lui | 14 |
| Raffaele Baffa | 9 |
| Lan Xie | 8 |
| Hong Ma | 7 |
| Guang Mei Yan | 7 |
| Rong Gang Xie | 7 |
| Ya Chao Zhao | 6 |
| Hua Qing Guo | 6 |
| Hua Mao Wang | 6 |
| Zong Hai Li | 6 |
| Xiang Ke Zhao | 5 |
| Chun Hai Fan | 5 |
| Leigh Hsu | 5 |
| Sylvie Peltier | 4 |
- Bourse
- Insiders
- Bing Sen Guo
- Connexions Sociétés
